Fingerprint
Dive into the research topics of 'Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome‒positive leukemias'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome‒positive leukemias
Vamsi Kota, Tim H. Brümmendorf, Carlo Gambacorti-Passerini, Jeff H. Lipton, Dong Wook Kim, Fiona An, Eric Leip, Rocco J. Crescenzo, Roxanne Ferdinand, Jorge E. Cortes
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations